Document Detail


Are proton pump inhibitors a new antidiabetic drug? A cross sectional study.
MedLine Citation:
PMID:  22174957     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: To investigate the effect of proton pump inhibitors (PPIs) on glycemic control (HbA1c) in type 2 diabetic patients.
METHODS: A cross-sectional study of consecutive in-patients admitted to hospital in any department during the first semester of the year 2010 who had a recent HbA1c measurement. The study excluded those with a diagnosis of hyperglycemic decompensation, diabetic onset or pregnancy. It compared HbA1c levels of those taking PPIs and those not.
RESULTS: A total of 97 patients were recruited. The average HbA1C level was 7.0% ± 1.2%. Overall PPI consumption was 55.7%. HbA1c was significantly lower in individuals who took PPIs: -0.6%, 95% CI: -0.12 to -0.83. People who used PPIs with some type of insulin therapy had a HbA1c reduction by -0.8%, 95% CI: -0.12 to -1.48. For the rest of subgroup analysis based on the antidiabetic drug used, PPI consumption always exhibited lower HbA1c levels.
CONCLUSION: PPIs seems to be consistently associated with better glycemic control in type 2 diabetes. HbA1c reduction observed is similar to incretin-based therapies.
Authors:
Diana Boj-Carceller; Pilar Bocos-Terraz; Miguel Moreno-Vernis; Alejandro Sanz-Paris; Pablo Trincado-Aznar; Ramón Albero-Gamboa
Related Documents :
3290917 - Incidence, prevalence and risk factors for non-insulin-dependent diabetes mellitus.
8528247 - Genetic analysis of non-insulin dependent diabetes mellitus in the gk rat.
1756017 - Hla antigens in insulin-dependent diabetes mellitus.
21128897 - Sodium-glucose co-transporter 2 inhibitors: from apple tree to 'sweet pee'.
15653197 - Insulin autoantibodies in cord blood from neonates with and without a sibling with type...
6371957 - Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenoco...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  World journal of diabetes     Volume:  2     ISSN:  1948-9358     ISO Abbreviation:  World J Diabetes     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101547524     Medline TA:  World J Diabetes     Country:  China    
Other Details:
Languages:  eng     Pagination:  217-20     Citation Subset:  -    
Affiliation:
Diana Boj-Carceller, Alejandro Sanz-Paris, Pablo Trincado- Aznar, Ramón Albero-Gamboa, Endocrinology and Nutrition Unit, Hospital Miguel Servet, 50009 Zaragoza, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is perinatal neuroendocrine programming involved in the developmental origins of metabolic disorders...
Next Document:  Evaluation of health research: measuring costs and socioeconomic effects.